Oberland Capital

Private

#Healthcare Structured Capital #Late-Stage Biopharma #Royalty Financing

Oberland Capital is a healthcare-focused investment firm providing structured capital to commercial-stage and late-stage clinical biopharma companies. In 2026 it announced up to $400M in financing to MeiraGTx to support eye gene therapy commercialization.

Company Info

Sector:Investment Firm / Healthcare

Headquarters:New York, New York, USA

Founded:2013

Website:oberlandcapital.com/